Dialectical Behavior Therapy for smoking cessation in high-risk veterans
Official title: Dialectical Behavior Therapy for Smoking Cessation in High Risk Veterans
Run by Veterans Medical Research Foundation · NCT06687577 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new smoking cessation program that combines regular treatment with Dialectical Behavior Therapy to help high-risk veterans quit smoking and manage their emotions better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Veterans Medical Research Foundation Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT06687577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are veterans receiving VA healthcare who exhibit multiple indicators of elevated suicide risk.
✕Probably not a fit
Patients with cognitive impairment or those unable to attend virtual interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial focuses on veterans who smoke and are at high risk for suicide, aiming to evaluate the effectiveness of a novel smoking cessation treatment that combines standard behavioral approaches with Dialectical Behavior Therapy (DBT). The study recognizes that individuals with emotional dysregulation, often excluded from cessation programs, may benefit from tailored interventions. Participants will be assigned to either receive usual cessation treatment or the DBT-enhanced approach, which aims to improve emotional regulation and support smoking cessation efforts. The trial seeks to address a significant health disparity among veterans by providing a targeted intervention for those with behavioral health challenges.
Why it matters
Potential benefit: If successful, this approach could significantly improve smoking cessation rates and mental health outcomes for high-risk veterans.
How similar studies have gone: Preliminary empirical work suggests that DBT may be effective for smoking cessation, indicating potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veteran receiving VA healthcare * multiple indicators of elevated suicide risk in 6 month period Exclusion Criteria: * cognitive impairment * unable to attend virtual intervention
Where it's running
-
Veterans Medical Research Foundation
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Neal M. Doran — Veterans Medical Research Foundation / VA
- Study coordinator: Neal M. Doran
- Email: nmdoran@health.ucsd.edu
- Phone: 858-552-8585
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Volitional Help Sheets to Support Smoking Cessation in Clinical Care
This pilot tests whether adding a short, personalized if-then planning tool helps people in a French clinic quit smoking when used alongside usual care.
-
How people disclose suicidal thoughts and get support in rural eastern Uganda
This study tests how disclosure of suicidal thoughts or severe distress affects social support or harm, and who should be involved in future help.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Extended tobacco support for people experiencing homelessness
This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.
-
Semaglutide to help people with type 2 diabetes quit smoking
This pilot will test whether adding semaglutide to combination nicotine replacement helps adults with type 2 diabetes quit smoking and limits post-quit weight gain.
-
Varenicline-based approach to help Veterans who smoke see if they can reduce smoking and try to quit
This study tests whether varenicline, plus motivational support, helps Veterans who aren’t ready to quit reduce smoking and make quit attempts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.